POPULARITY
Building miniature brains may sound like a page out of a science fiction novel, but fact is indeed stranger than fiction. Researchers around the world grow brain organoids—3D miniature brains—to better understand brain development, aging, injury, and other disorders, as well as to test new treatment strategies. Some scientists take brain building to the next level by launching their brain organoids into outer space. In this episode, Iris Kulbatski from The Scientist spoke with Alysson Muotri, a University of California, San Diego professor and Stem Cell Program director to learn more about how microgravity affects the cellular and molecular biology of brain organoids and how these discoveries can improve human health. The Scientist Speaks is a podcast produced by The Scientist's Creative Services Team. Our podcast is by scientists and for scientists. Once a month, we bring you the stories behind news-worthy molecular biology research. This month's episode is sponsored by ACROBiosystems and Molecular Devices.
Why explore stem cells in space when we have the comfort of Earth's laboratories? Join Robert A.J. Signer, Ph.D., alongside Catriona Jamieson, M.D., Ph.D., and Alysson Muotri, Ph.D., as they delve into the untapped potential of space experiments for expediting medical breakthroughs. Patient advocate Alexandria Allen offers a poignant narrative, revealing the profound impact such research has had on her personal health journey. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 39733]
Why explore stem cells in space when we have the comfort of Earth's laboratories? Join Robert A.J. Signer, Ph.D., alongside Catriona Jamieson, M.D., Ph.D., and Alysson Muotri, Ph.D., as they delve into the untapped potential of space experiments for expediting medical breakthroughs. Patient advocate Alexandria Allen offers a poignant narrative, revealing the profound impact such research has had on her personal health journey. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 39733]
Why explore stem cells in space when we have the comfort of Earth's laboratories? Join Robert A.J. Signer, Ph.D., alongside Catriona Jamieson, M.D., Ph.D., and Alysson Muotri, Ph.D., as they delve into the untapped potential of space experiments for expediting medical breakthroughs. Patient advocate Alexandria Allen offers a poignant narrative, revealing the profound impact such research has had on her personal health journey. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 39733]
Why explore stem cells in space when we have the comfort of Earth's laboratories? Join Robert A.J. Signer, Ph.D., alongside Catriona Jamieson, M.D., Ph.D., and Alysson Muotri, Ph.D., as they delve into the untapped potential of space experiments for expediting medical breakthroughs. Patient advocate Alexandria Allen offers a poignant narrative, revealing the profound impact such research has had on her personal health journey. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 39733]
Why explore stem cells in space when we have the comfort of Earth's laboratories? Join Robert A.J. Signer, Ph.D., alongside Catriona Jamieson, M.D., Ph.D., and Alysson Muotri, Ph.D., as they delve into the untapped potential of space experiments for expediting medical breakthroughs. Patient advocate Alexandria Allen offers a poignant narrative, revealing the profound impact such research has had on her personal health journey. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 39733]
Why explore stem cells in space when we have the comfort of Earth's laboratories? Join Robert A.J. Signer, Ph.D., alongside Catriona Jamieson, M.D., Ph.D., and Alysson Muotri, Ph.D., as they delve into the untapped potential of space experiments for expediting medical breakthroughs. Patient advocate Alexandria Allen offers a poignant narrative, revealing the profound impact such research has had on her personal health journey. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 39733]
Why explore stem cells in space when we have the comfort of Earth's laboratories? Join Robert A.J. Signer, Ph.D., alongside Catriona Jamieson, M.D., Ph.D., and Alysson Muotri, Ph.D., as they delve into the untapped potential of space experiments for expediting medical breakthroughs. Patient advocate Alexandria Allen offers a poignant narrative, revealing the profound impact such research has had on her personal health journey. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 39733]
Why explore stem cells in space when we have the comfort of Earth's laboratories? Join Robert A.J. Signer, Ph.D., alongside Catriona Jamieson, M.D., Ph.D., and Alysson Muotri, Ph.D., as they delve into the untapped potential of space experiments for expediting medical breakthroughs. Patient advocate Alexandria Allen offers a poignant narrative, revealing the profound impact such research has had on her personal health journey. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 39733]
Why explore stem cells in space when we have the comfort of Earth's laboratories? Join Robert A.J. Signer, Ph.D., alongside Catriona Jamieson, M.D., Ph.D., and Alysson Muotri, Ph.D., as they delve into the untapped potential of space experiments for expediting medical breakthroughs. Patient advocate Alexandria Allen offers a poignant narrative, revealing the profound impact such research has had on her personal health journey. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 39733]
Graduado em Ciências Biológicas pela Universidade Estadual de Campinas (Unicamp) e com doutorado em Biologia Genética pela Universidade de São Paulo (USP), Alysson Muotri é pesquisador e professor. A experiência com o autismo veio com a paternidade e também com a pesquisa. Além de também ter atuado como colunista de ciência do G1, publicou dois livros e foi um dos fundadores da startup Tismoo. Com essas credenciais, ele é o entrevistado de maio no Espectros. O Espectros é o podcast de entrevistas da Revista Autismo. Acesse em: http://canalautismo.com.br/espectros
Dr. Alysson Muotri, PhD é professor na Universidade da Califórnia - San Diego, e seus estudos se concentram em entender o cérebro humano a partir de uma perspectiva evolutiva e de desenvolvimento. Dr Muotri cria "organóides cerebrais” ou MINICÉREBRO em laboratório para estudar as propriedades evolutivas que nos diferenciam dos outros primatas, como os Neandertais. Seu trabalho ajuda a entender doenças neurológicas complexas, identificar novas terapias e reduzir o tempo para levar novos medicamentos a ensaios clínicos. Ele revelará descobertas surpreendentes sobre estes estudo; Considero que o avanço científico liderado pelo Dr Muotri merece o prêmio Nobel de Medicina.Sintonize o Podbrand agora!https://podbrand.bio.link@BOrganoid@alyssonmuotrihttps://www.facebook.com/muotri/https://www.youtube.com/@alyssonmuotri7220/featuredhttps://www.linkedin.com/in/alysson-muotri-64499aa/ASSINE A REVISTA AUTISMOhttps://rebrand.ly/assinerevistaautismoRevista AutismoCanalAutismo.com.br/revistahttps://instagram.com/RevistaAutismohttps://www.linkedin.com/company/RevistaAutismoTismoo Biotechwww.tismoo.ushttps://www.instagram.com/_tismoo/ https://www.linkedin.com/company/tismoo/Tismoo me (única rede social do mundo dedicada ao autismo)Tirmoo.mehttps://www.instagram.com/tismoo.me/https://www.linkedin.com/company/tismoo-mePODBRAND, o podcast sobre DESIGN, ESTRATÉGIA e INOVAÇÃO.Nosso objetivo é que você alcance SUA MELHOR VERSÃO.NOTE: A música está sob licença de copyright.https://lnkd.in/d39mudbH#design #estratégia #inovação #branding#designexport #designestratégico #valordemarca #opodcastdodesign #gestãodevalor#mauriciomedeirosoficial #empreendedorismocriativo#gestãodeinovação #podbrand #suamelhorversão #podbrandoficial #designdeserviços #TOC #theoryofconstraints#teoriadasrestrições #construçãodevalor #fashionglobalbrand #designdaciência Hosted on Acast. See acast.com/privacy for more information.
Please support the podcast by taking our short listener survey: https://www.surveymonkey.com/r/intotheimpossible Be sure to watch the video of this episode on YouTube here: https://youtu.be/hDKGF5W4Qis?sub_confirmation=1 Where does consciousness come from? Can we cure autism? Can we grow a human BRAIN in Space? Dr. Alysson Muotri joins me to discuss all these fascinating questions and more. Brain organoids are lab-grown minibrains that mimic structural and functional features of full-size brains. They are created by culturing pluripotent stem cells in a three-dimensional rotational bioreactor, and they develop over a course of months. Brain organoids have emerged as novel model systems that can be used to investigate human brain development and disorders34, as well as evolutionary studies and neural network research Muotri is a Professor at the Departments of Pediatrics and Cellular & Molecular Medicine at UC San Diego, an Associate Director of CARTA, The Center for Research and Training in Anthropology, and Director of the Stem Cell Program, and of the Archealization Center (ArchC) at UC San Diego. He moved to the Salk Institute as Pew Latin America Fellow in 2002 for postdoctoral training in the fields of neuroscience and stem cell biology. His research focuses on brain evolution and modeling neurological diseases using human-induced pluripotent stem cells and brain organoids. He has an additional focus on solving one of life's greatest mysteries: What is it that makes us uniquely human? Our unique social brains are one of the key distinguishing factors between humans and other primates. We are even very different from our closest relatives, the Neanderthals. His work has implications for the generation of human disease models by determining the molecular and cellular mechanisms driving neurological complex disorders, such as autism. It is also creating opportunities for identifying and testing novel therapeutic approaches. Understanding the evolutionary path and the tradeoffs of the modern human brain will likely illuminate the origins of human disease. Dr. Moutri has received several awards, including the prestigious NIH Director's New Innovator Award, NARSAD, Emerald Foundation Young Investigator Award, Surugadai Award, Rock Star of Innovation, NIH EUREKA Award, and two Telly Awards for Excellence in Science Communication. Links: Department of Cellular and Molecular Medicine: cmm.ucsd.edu Center for Academic Research and Training in Anthropogeny: carta.anthropogeny.org/users/alysson-muotri the Archealization Center: Archc.ucsd.edu Subscribe to the Jordan Harbinger Show for amazing content from Apple's best podcast of 2018! https://www.jordanharbinger.com/podcasts Please leave a rating and review: On Apple devices, click here, https://apple.co/39UaHlB On Spotify it's here: https://spoti.fi/3vpfXok On Audible it's here https://tinyurl.com/wtpvej9v Find other ways to rate here: https://briankeating.com/podcast Support the podcast on Patreon https://www.patreon.com/drbriankeating or become a Member on YouTube- https://www.youtube.com/channel/UCmXH_moPhfkqCk6S3b9RWuw/join To advertise with us, contact advertising@airwavemedia.com Learn more about your ad choices. Visit megaphone.fm/adchoices
How do research communities contend with controversial science? J. Benjamin Hurlbut, Ph.D., Arizona State University, Alysson Muotri, Ph.D., UC San Diego, Matthew Porteus, M.D., Ph.D., Stanford University, and Jacob (Yaqub) Hanna, M.D., Ph.D., Weizmann Institute of Science, explore controversial case studies and the limitations of scientific deliberation/dissent/ambivalence. Series: "Stem Cell Channel" [Health and Medicine] [Humanities] [Science] [Show ID: 38729]
How do research communities contend with controversial science? J. Benjamin Hurlbut, Ph.D., Arizona State University, Alysson Muotri, Ph.D., UC San Diego, Matthew Porteus, M.D., Ph.D., Stanford University, and Jacob (Yaqub) Hanna, M.D., Ph.D., Weizmann Institute of Science, explore controversial case studies and the limitations of scientific deliberation/dissent/ambivalence. Series: "Stem Cell Channel" [Health and Medicine] [Humanities] [Science] [Show ID: 38729]
How do research communities contend with controversial science? J. Benjamin Hurlbut, Ph.D., Arizona State University, Alysson Muotri, Ph.D., UC San Diego, Matthew Porteus, M.D., Ph.D., Stanford University, and Jacob (Yaqub) Hanna, M.D., Ph.D., Weizmann Institute of Science, explore controversial case studies and the limitations of scientific deliberation/dissent/ambivalence. Series: "Stem Cell Channel" [Health and Medicine] [Humanities] [Science] [Show ID: 38729]
How do research communities contend with controversial science? J. Benjamin Hurlbut, Ph.D., Arizona State University, Alysson Muotri, Ph.D., UC San Diego, Matthew Porteus, M.D., Ph.D., Stanford University, and Jacob (Yaqub) Hanna, M.D., Ph.D., Weizmann Institute of Science, explore controversial case studies and the limitations of scientific deliberation/dissent/ambivalence. Series: "Stem Cell Channel" [Health and Medicine] [Humanities] [Science] [Show ID: 38729]
How do research communities contend with controversial science? J. Benjamin Hurlbut, Ph.D., Arizona State University, Alysson Muotri, Ph.D., UC San Diego, Matthew Porteus, M.D., Ph.D., Stanford University, and Jacob (Yaqub) Hanna, M.D., Ph.D., Weizmann Institute of Science, explore controversial case studies and the limitations of scientific deliberation/dissent/ambivalence. Series: "Stem Cell Channel" [Health and Medicine] [Humanities] [Science] [Show ID: 38729]
How do research communities contend with controversial science? J. Benjamin Hurlbut, Ph.D., Arizona State University, Alysson Muotri, Ph.D., UC San Diego, Matthew Porteus, M.D., Ph.D., Stanford University, and Jacob (Yaqub) Hanna, M.D., Ph.D., Weizmann Institute of Science, explore controversial case studies and the limitations of scientific deliberation/dissent/ambivalence. Series: "Stem Cell Channel" [Health and Medicine] [Humanities] [Science] [Show ID: 38729]
How do research communities contend with controversial science? J. Benjamin Hurlbut, Ph.D., Arizona State University, Alysson Muotri, Ph.D., UC San Diego, Matthew Porteus, M.D., Ph.D., Stanford University, and Jacob (Yaqub) Hanna, M.D., Ph.D., Weizmann Institute of Science, explore controversial case studies and the limitations of scientific deliberation/dissent/ambivalence. Series: "Stem Cell Channel" [Health and Medicine] [Humanities] [Science] [Show ID: 38729]
How do research communities contend with controversial science? J. Benjamin Hurlbut, Ph.D., Arizona State University, Alysson Muotri, Ph.D., UC San Diego, Matthew Porteus, M.D., Ph.D., Stanford University, and Jacob (Yaqub) Hanna, M.D., Ph.D., Weizmann Institute of Science, explore controversial case studies and the limitations of scientific deliberation/dissent/ambivalence. Series: "Stem Cell Channel" [Health and Medicine] [Humanities] [Science] [Show ID: 38729]
Alysson Muotri discusses modeling Pitt-Hopkins syndrome (PTHS) using stem cells and brain organoids. He shares how rescuing TCF4 expression with CRISPR-mediated epigenetic induction of AAV vector delivery provides a gateway for targeted therapeutics for PTHS and related conditions. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 38516]
Alysson Muotri discusses modeling Pitt-Hopkins syndrome (PTHS) using stem cells and brain organoids. He shares how rescuing TCF4 expression with CRISPR-mediated epigenetic induction of AAV vector delivery provides a gateway for targeted therapeutics for PTHS and related conditions. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 38516]
Alysson Muotri discusses modeling Pitt-Hopkins syndrome (PTHS) using stem cells and brain organoids. He shares how rescuing TCF4 expression with CRISPR-mediated epigenetic induction of AAV vector delivery provides a gateway for targeted therapeutics for PTHS and related conditions. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 38516]
Alysson Muotri discusses modeling Pitt-Hopkins syndrome (PTHS) using stem cells and brain organoids. He shares how rescuing TCF4 expression with CRISPR-mediated epigenetic induction of AAV vector delivery provides a gateway for targeted therapeutics for PTHS and related conditions. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 38516]
Alysson Muotri discusses modeling Pitt-Hopkins syndrome (PTHS) using stem cells and brain organoids. He shares how rescuing TCF4 expression with CRISPR-mediated epigenetic induction of AAV vector delivery provides a gateway for targeted therapeutics for PTHS and related conditions. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 38516]
Alysson Muotri discusses modeling Pitt-Hopkins syndrome (PTHS) using stem cells and brain organoids. He shares how rescuing TCF4 expression with CRISPR-mediated epigenetic induction of AAV vector delivery provides a gateway for targeted therapeutics for PTHS and related conditions. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 38516]
Alysson Muotri discusses modeling Pitt-Hopkins syndrome (PTHS) using stem cells and brain organoids. He shares how rescuing TCF4 expression with CRISPR-mediated epigenetic induction of AAV vector delivery provides a gateway for targeted therapeutics for PTHS and related conditions. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 38516]
Alysson Muotri discusses modeling Pitt-Hopkins syndrome (PTHS) using stem cells and brain organoids. He shares how rescuing TCF4 expression with CRISPR-mediated epigenetic induction of AAV vector delivery provides a gateway for targeted therapeutics for PTHS and related conditions. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 38516]
What is gene therapy and how does it relate to autism? Alysson Muotri, Ph.D., contextualizes the autism spectrum, defines gene therapy, shares how human stem cells can contribute to research, and lays out how gene therapy could be used in the future. Series: "Autism Tree Project Annual Neuroscience Conference" [Health and Medicine] [Science] [Show ID: 38387]
What is gene therapy and how does it relate to autism? Alysson Muotri, Ph.D., contextualizes the autism spectrum, defines gene therapy, shares how human stem cells can contribute to research, and lays out how gene therapy could be used in the future. Series: "Autism Tree Project Annual Neuroscience Conference" [Health and Medicine] [Science] [Show ID: 38387]
What is gene therapy and how does it relate to autism? Alysson Muotri, Ph.D., contextualizes the autism spectrum, defines gene therapy, shares how human stem cells can contribute to research, and lays out how gene therapy could be used in the future. Series: "Autism Tree Project Annual Neuroscience Conference" [Health and Medicine] [Science] [Show ID: 38387]
What is gene therapy and how does it relate to autism? Alysson Muotri, Ph.D., contextualizes the autism spectrum, defines gene therapy, shares how human stem cells can contribute to research, and lays out how gene therapy could be used in the future. Series: "Autism Tree Project Annual Neuroscience Conference" [Health and Medicine] [Science] [Show ID: 38387]
What is gene therapy and how does it relate to autism? Alysson Muotri, Ph.D., contextualizes the autism spectrum, defines gene therapy, shares how human stem cells can contribute to research, and lays out how gene therapy could be used in the future. Series: "Autism Tree Project Annual Neuroscience Conference" [Health and Medicine] [Science] [Show ID: 38387]
What is gene therapy and how does it relate to autism? Alysson Muotri, Ph.D., contextualizes the autism spectrum, defines gene therapy, shares how human stem cells can contribute to research, and lays out how gene therapy could be used in the future. Series: "Autism Tree Project Annual Neuroscience Conference" [Health and Medicine] [Science] [Show ID: 38387]
What is gene therapy and how does it relate to autism? Alysson Muotri, Ph.D., contextualizes the autism spectrum, defines gene therapy, shares how human stem cells can contribute to research, and lays out how gene therapy could be used in the future. Series: "Autism Tree Project Annual Neuroscience Conference" [Health and Medicine] [Science] [Show ID: 38387]
#autism #autismawareness #genetherapy #podcast #toctw #neuroscience A Gene Therapy Reverses Effects of Pitt-Hopkins Syndrome a form of Autism-Linked Mutation in Human Brain Organoids Dr. Alysson R. Muotri, a professor in the Departments of Pediatrics and Cellular & Molecular Medicine at the University of California, San Diego, is focusing his research on solving one of life's greatest mysteries- What is it that makes us uniquely human? Research tells us that one of the most influential characteristics of modern humans is our sophisticated brains, and all of the abilities that its complexity grants us. Our unique social brains are one of the key distinguishing factors between humans and other primates. We are even very different from our closest relatives, the Neanderthals, whose brains were limited in their ability to create technology, art, imagination and overall culture. Dr. Muotri is studying the brain from an evolutionary and developmental perspective, differentiating stem cells to recreate "brain organoids" in the controlled setting of a lab. This work has implications for the generation of human disease models by determining the molecular and cellular mechanisms driving neurological complex disorders, such as autism. It is also creating opportunities for identifying and testing novel therapeutic approaches; the nature of this work reduces the amount of time required for moving new drugs to clinical trials. Gaining a clearer understanding of human brain evolution is crucial for interpreting human genetic variants which lead to disease. Some of the evolutionary properties that make us uniquely human and allow us to live the advanced lifestyle we enjoy are also a root cause for a number of disorders. Our brain grants us far greater processing power than any other species, but a complex brain came with a cost: it increases the opportunity for neurological diseases. Thus, understanding the evolutionary path and the tradeoffs of the modern human brain will likely illuminate the origins of human disease. https://www.linkedin.com/in/alysson-muotri-64499aa https://medschool.ucsd.edu/som/pediatrics/research/labs/muotri-lab/Pages/default.aspx https://tismoo.us
Today we're talking to Alysson Muotri, Professor at University of California, San Diego; and we discuss how Alysson is growing brains in a lab, and what's on the cutting edge of modern autism and genetic research. All of this right here, right now, on the Modern CTO Podcast!
Welcome to Science Philosophy in a Flash, a mini podcast series produced by The Scientist's Creative Services Team. In this series, we highlight researchers' unique outlooks on what it means to be a scientist. Alysson Muotri, a professor at the University of California, San Diego and director of the Stem Cell program, pushes the boundaries of neuroscience research. He builds brains for a living, then sends them on missions to outer space. Motivated by curiosity and creativity, his work is advancing scientists' understanding of brain development and aging. In this episode narrated by Niki Spahich, Iris Kulbatski from The Scientist's Creative Services Team spoke with Muotri to learn more about what being a scientist means to him. To learn more about Muotri's work, check out the upcoming ebook Next-Level Organoids, available on July 29th here.
A model of human cortical development could be used to instruct novel computational learning approaches. Alysson Muotri, Phd, Sujeeth Bharadwaj, PhD, Weiwei Yang, and Gabrial Silva, MSc, PhD, discuss the promise, the problems, and the potential when biology and artificial intelligence meet. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 37556]
A model of human cortical development could be used to instruct novel computational learning approaches. Alysson Muotri, Phd, Sujeeth Bharadwaj, PhD, Weiwei Yang, and Gabrial Silva, MSc, PhD, discuss the promise, the problems, and the potential when biology and artificial intelligence meet. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 37556]
A model of human cortical development could be used to instruct novel computational learning approaches. Alysson Muotri, Phd, Sujeeth Bharadwaj, PhD, Weiwei Yang, and Gabrial Silva, MSc, PhD, discuss the promise, the problems, and the potential when biology and artificial intelligence meet. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 37556]
A model of human cortical development could be used to instruct novel computational learning approaches. Alysson Muotri, Phd, Sujeeth Bharadwaj, PhD, Weiwei Yang, and Gabrial Silva, MSc, PhD, discuss the promise, the problems, and the potential when biology and artificial intelligence meet. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 37556]
A model of human cortical development could be used to instruct novel computational learning approaches. Alysson Muotri, Phd, Sujeeth Bharadwaj, PhD, Weiwei Yang, and Gabrial Silva, MSc, PhD discuss the promise, the problems, and the potential when biology and artificial intelligence meet. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 37556]
A model of human cortical development could be used to instruct novel computational learning approaches. Alysson Muotri, Phd, Sujeeth Bharadwaj, PhD, Weiwei Yang, and Gabrial Silva, MSc, PhD discuss the promise, the problems, and the potential when biology and artificial intelligence meet. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 37556]
Understanding the evolutionary path and the tradeoffs of the modern human brain will likely illuminate the origins of human disease. Alysson Muotri explains his research using stem cells to model Neanderthal brains in an effort to better understand our origins as well as our future. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 37018]
Understanding the evolutionary path and the tradeoffs of the modern human brain will likely illuminate the origins of human disease. Alysson Muotri explains his research using stem cells to model Neanderthal brains in an effort to better understand our origins as well as our future. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 37018]
Understanding the evolutionary path and the tradeoffs of the modern human brain will likely illuminate the origins of human disease. Alysson Muotri explains his research using stem cells to model Neanderthal brains in an effort to better understand our origins as well as our future. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 37018]
Understanding the evolutionary path and the tradeoffs of the modern human brain will likely illuminate the origins of human disease. Alysson Muotri explains his research using stem cells to model Neanderthal brains in an effort to better understand our origins as well as our future. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 37018]
Alysson Muotri aims to build a ‘thinking’ brain as a model for autism — even if his colleagues consider that work controversial.